Evidence map›Paper›PMID 37247108›Full record

ArticleJournal of clinical immunology2023

Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient.

Cléa Melenotte, Robert Ratiney, Olivier Hermine, Marie-Elisabeth Bougnoux, Fanny Lanternier

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Current infectious disease management challenges in inborn errors of immunity.Annals of clinical microbiology and antimicrobials · 2025
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cléa MelenotteService de Maladies Infectieuses et Tropicales, Faculté de Médecine, Hôpital Necker Enfants Malades, Assistance Publique des Hôpitaux de Paris, Université Paris-Cité, 149 Rue de Sèvres, 75015, Paris, France. clea.melenotte@aphp.fr.ORCID 0000-0003-3159-1061
Robert RatineyService de Pharmacie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Paris, France.
Olivier HermineService d'Hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Paris, France.
Marie-Elisabeth BougnouxDepartment of Mycology-Parasitology, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Hôpital Necker Enfants Malades, Paris, France.
Fanny LanternierService de Maladies Infectieuses et Tropicales, Faculté de Médecine, Hôpital Necker Enfants Malades, Assistance Publique des Hôpitaux de Paris, Université Paris-Cité, 149 Rue de Sèvres, 75015, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AzolesCandidiasis, Chronic MucocutaneousAntifungal AgentsEchinocandinsGain of Function MutationHumansAntifungal AgentsAzolesEchinocandinsRezafungin

Identifiers

PMID37247108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.